Erythropoietin pathophysiology and erythropoietin deficiency anemia.
Cazzola
Mario
M
University of Pavia Medical School, Pavia, Italy.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001327:Autoimmune Diseases / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D015687:Cell Hypoxia; D018572:Disease-Free Survival; D004311:Double-Blind Method; D004921:Erythropoietin / Q000009:adverse effects / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology* / Q000627:therapeutic use; D006333:Heart Failure / Q000097:blood / Q000150:complications; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000097:blood / Q000150:complications / Q000503:physiopathology; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000150:complications; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications; D009369:Neoplasms / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin